Association between Secretor Status of ABH Substances and HIV 1& 2 P24 Antigen Screening Status Amongst Eligible Blood Donors with Previously Screened HIV 1& 2 Antibody- Negative Status in Calabar, Nigeria

Main Article Content

Forwah Jacques Ndeh
Ebot Walter Ojong
Immaculate Ihuoma Ekeagba

Abstract

Aims: New hypotheses suggest non-secretors may be less vulnerable to the HIV infection than secretors.  Association between secretor status and HIV P24 antigen status was studied in 400 HIV antibody sero-negative   prospective blood donors aged above 20 years of both genders recruited within Calabar, Nigeria.

Materials and Methods: About  3 ml of saliva and 5ml of blood samples  were  analyzed  for HIV  antibodies  using Stat Pak (by Chembio Diagnostic System International), Determine (by Inverness Medical Japan Cooperation, Limited), Unigold (by Trinity Biotech, USA) rapid test Kits  and  antigens  using HIV P24 antigens Combi test Kits (by Inverness Medical Japan Cooperation, Limited) respectively.  Secretor Status done using Anti-H Lectin reagent by BIOTEC Laboratories Limited, UK.

Results: Out of 400 samples, 80 (20%) were non-secretors and 320(80%) secretors. while 6(8.1%) non-secretor  and 9(2.9%) secretor samples  reacted to  HIV P24  antigen screening test. Chi-Square (X2=5.655, P=0.025) showed significant difference between secretor and non-secretors based on   gender. No significant difference exits between HIV p24 antigen status and secretor status (chi squared X2 =0.007, P =0.9) and   secretor status and the three HIV Antibody test kits (F -ratio = 1.7997, P =0.307)

Conclusion: No significant association found between secretor status and HIV P24 antigen status but detectable P24 antigens were more in secretors than non-secretos.

Keywords:
Association, secretor status, ABH substances, P24 antigen screening status, HIV 1& 2 antibody negative, appararently healthy employees, eligible blood donors.

Article Details

How to Cite
Ndeh, F. J., Ojong, E. W., & Ekeagba, I. I. (2020). Association between Secretor Status of ABH Substances and HIV 1& 2 P24 Antigen Screening Status Amongst Eligible Blood Donors with Previously Screened HIV 1& 2 Antibody- Negative Status in Calabar, Nigeria. Asian Journal of Immunology, 4(4), 20-35. Retrieved from https://journalaji.com/index.php/AJI/article/view/30142
Section
Original Research Article

References

Alexander W. An inquiry into the distribution of the blood group patient suffering from malignant disease. British Journal of Experimental Pathology. 1921;2:66-69. [PubMed] [Google Scholar]

Aird I, Bentall HH, Mehigan JA, Roberts JA. The blood groups in relation to peptic ulceration and carcinoma of colon, rectum, breast, and bronchus; an association between the ABO groups and peptic ulceration. British Medical Journal. (1954)7;488(3):315-21. [PubMed] [Google Scholar]

Mourant AE. Identification of the Antibody Anti‐e, International of Journal of Transfusion Medicine Vox Sanguinis. 1983;44(4):260-26. Wiley Online Libarary Available:https://doi.org/10.1111/j.1423-0410.1983.tb01892.x[PubMed] [Google Scholar]

Dickey W, Wylie JD, Collins JS, Porter KG, Watson RG, McLoughlin JC. Lewis phenotype, secretor status, and coeliac disease. Gut. 1994;35(6):769-770. [PubMed] [Google Scholar]

Mollicone R, Cailleau A, Oriol R. Molecular genetics of H, Se, Lewis and other fucosyltransferase genes.Transfusion in Clinical Biology. 1995;2(4):235-42. [PubMed] [Google Scholar]

Nakano T, Shimanuki T, Matsushita M, Koyama I, Inoue I, Katayama S, Alpers DH, Komoda T. Involvement of intestinal alkaline phosphatase in serum apolipoprotein B-48 level and its association with ABO and secretor blood group types. Biochemistry, Biophysical Research Communication. (2006),341(1):page 338 [PubMed] [Google Scholar]

Sayal SK, Das AL, Nema SK. Study of blood groups in HIV seropositive patients. Indian Journal of Dermatology Venereology Leprology. 1996;62:295-7. [PubMed] [Google Scholar]

Martin L. Olsson, Nicole Lund, Stephanie Ramkumar, Darinka Sakac, Vered Yahalom, Cyril Levene, Asa Hellberg, Xue-Zhong Ma, Beth Binnington, Daniel Jung. Blood group antigen provides protection against HIV-1 infection. Blood. 2009;0(03):143. [PubMed] [Google Scholar]

Lund N. The human Pk histo-blood group antigen provides protection against HIV-1 infection. Blood. E.pub ahead of print; 2009. [PubMed] [Google Scholar]

Imagawa DT, Lee MH, Wolinsky SM. Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. New England Journal of Medicine. 1989;320:1458-1462. [PubMed] [Google Scholar].

Larry Reimer Susan Mottice, Charles Schable, Patrick Sullivan, Allyn Nakashima, Mark Rayfield, Randy Den, Charles Brokopp. Absence of Detectable Antibody in a Patient Infected with Human Immunodeficiency Virus in Clinical Infectious Diseases. 1997;25:98–100 . [PubMed] [Google Scholar].

Centers for Disease Control and Prevention (CDC), Persistent Lack of Detectable HIV-1 Antibody In a Person With HIV Infection -- Utah, Morbidity and Mortality Weekly Report (MMWR), 1996/45(09):181-8. [email protected]

Joseph Sonnabend, Natural Immunity and HIV journal of infection disease, 2010 ,19/10/10 POZ.

Ali S, Niang MAF, N'doye I. Secretor Polymorphism and Human Immunodeficiency Virus Infection in Senegalese Women. JID. 2000;181:737-9.[PubMed] [Google Scholar]

Rodés B, Toro C, Simón A, Soriano V. The Protective Role of FUT2 Gene in a Cohort of LTNP Compared to Other Factors Associated with Non-progression. In: Program and abstracts of the 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; 2006. San Francisco,Calif.AbstractH-1404.View slides: Download PowerPoint[PubMed] [Google Scholar]

Kindberg E, Hejdeman B, Brat G, Wahren B. A nonsense mutation (428G->A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection. AIDS. 200;20(5):685-689..[PubMed] [Google Scholar]

Secretor system, biology online in Encyclopaedia Britannica; written by The Editors of Encyclopaedia; 2020.

Rashmi Metgud, Nidhi Khajuria, Mamta, Gayathri Ramesh: Evaluation of the Secretor Status of ABO Blood Group Antigens in Saliva among Southern Rajasthan Population Using Absorption Inhibition Method, J Clin Diagn Res. 2016;10(2):ZC01–ZC03[PubMed] [Google Scholar]

Lehrs T, Putkonen T. Discovery of secretor status and the ABH blood groups substance in bodily secretions. Acta Soc. Med. Fenn. Duodecim Ser. A. 1930;14(2).[PubMed] [Google Scholar]

Schiff F. Zur Kenntnis Der Blutantigene Des Shigabazillus. Z. Immun. Forsch. 1934;82:46. [PubMed] [Google Scholar]

D’Adamo PJ, Kelly GS. Metabolic and immunologic consequences of ABH secretor and Lewis subtype status. Alternative Medicine Review. 2001;6(4):390-4050. [PubMed] [Google Scholar]

Morgan WTJ, Walkins Winifred M. The detection of a product of the blood group O gene and the relationship of the so-called O substance to the agglutinogen A and B ,British Journal of Experimental Pathology. 1948;29:159. [PubMed] [Google Scholar]

Clark CA, Price Evans DA, Mc Connell RB, Sheppard PM. Secretion of blood group antigens and peptic ulcers .British Medical Journal. 1959;I(225):603. [PubMed] [Google Scholar]

Mollicone R, Cailleau A, Oriol R. Molecular genetics of H, Se, Lewis and other fucosyltransferase genes.Transfusion in Clinical Biology. 1995;2(4):235-42, [PubMed] [Google Scholar]

Watkins WM. Biochemistry of the ABH and Lewis blood group substances. In : Advances in blood group. 1966;3. (Editors, Weiner A. S.Grume and Stratton). Page. 550-555 [PubMed] [Google Scholar]

Szulman AE. The ABH antigens in human tissues and secretion during embryonic development. Journal of Histochemistry. 1965;13:752. [PubMed] [Google Scholar]

World Health Organization Global Health Observatory (WHO GHO) data on HIV/AIDS 2020[PubMed] [Google Scholar]

United Nation Joint Programme on AIDS (UNAIDS) Global HIV/AIDS 2020 fact sheet[PubMed] [Google Scholar]

Fauci A, Masur H,Gelmann EP, Markham PO, Halin,B.H.and Lane H.C.The AIDS,an update annual of internal medicine. 1985;102:800-813 [PubMed] [Google Scholar]

Weiss RA. How does HIV cause AIDS? Science. 1993;260(5112):1273–9. [PubMed] [Google Scholar]

Douek DC, Roederer M, Koup RA. Emerging concepts in the immunopathogenesis of AIDS. Annu. Rev. Med. 2009;60:471–84[PubMed] [Google Scholar]

United Nation Joint Programme on AIDS ABUJA/GENEVA Declaration; 2020 Report, [PubMed] [Google Scholar]

Cross River State eMTCT Operation Plan for the Elimination of Mother -to- Child Transmission of HIV Bayelsa State Ministry of Health ,Family Health International- FHI 360 and United Nation Joint Programme on AIDS REPORT 2013-2015 [PubMed] [Google Scholar]

Osuchukwu NC, Onovo AA, Atobatcle AO, Nta IE. Disproportionate Burden of HIV Prevalence among Men and Women assessing HIV Testing and Counseling Services in Cross River State Nigeria ,IOSR Journal of Pharmacy and Biological Science (IOSR-JPBS). 2013;7(6):19-24. [PubMed] [Google Scholar]

Wahdan MH. Epidemiology of acquired immunodeficiency syndrome. Alexandria, World Health Organization, Regional Office for the Eastern Mediterranean; 1995. (WHO-EM/GPA/014/E/L/95). [PubMed] [Google Scholar]

Barré-Sinoussi F, Chermann JC, Rey F. Isolation of a T-lymphotropic retrovirus from a patient at risk For Acquired Immuno - Deficiency syndrome (AIDS). Science. 1983;220:868-871. [PubMed] [Google Scholar]

WHO. Guidelines for antimicrobial resistance surveillance. WHO Regional Publications; 2007. Eastern Mediterranean Series No. 151929021213, Border No. 1440015[PubMed] [Google Scholar]

UNAIDS. The latest statistics of the global HIV and AIDS epidemic: published by UNAIDS in November, 2009, refer to the end of 2008. [PubMed] [Google Scholar]

Alison Walkley. HIV transmission via transfusions in Africa remains high, MEDIAGLOBAL published by United Nations Secretariat, Room L-221 K, Dag Hammarskjold Library, New York, NY; 2009; 10017. Available:http://mediaglobal.org/article/2009-08-08/cote-divoire-approved-for-fi.[PubMed] [Google Scholar]

FMOH. Federal Ministry of Health, Nigeria: 'National Blood Transfusion Service- About Us; 2009.

Egesie OJ, Joseph DE, Egesie UG, Odeh CI. Trends in the incidence of hepatitis B, C and Human Immunodeficiency Virus among blood donors in a tertiary hospital in Nigeria. Journal of Medicine in the Tropics. 2011;13(1). (In press). [PubMed] [Google Scholar]

Coovadia H. Antiretroviral agents how best to protect infants from HIV and save their mothers from AIDS. New England Journal of Medicine. 2004;351(3):289–292. [PubMed] [Google Scholar]

Scott, Katherine C. Philip, Susan, Ahrens, Katherine, Kent, Charlotte K, Klausner Jeffrey. High Prevalence of Gonococcal and Chlamydial Infection in Men Who Have Sex With Men With Newly Diagnosed HIV Infection An Opportunity for Same-Day Presumptive Treatment JAIDS Journal of Acquired Im mune Deficiency Syndromes. 2008;48(1):109-112 DOI: 10.1097/QAI.0b013e318165dc0b[PubMed] [Google Scholar]Jayasri Basu, Seymour L. Romney, Ruth H. Angeletti, Sten H. Vermund, Edward Nieves, Anna S. Kadish, Magdy S. Mikhail, and George A. Orr (2009):Human Immunodeficiency Virus (HIV) Antigens and RNA in HIV-Seronegative Women with Cervical Intraepithelial Neoplasia, AIDS research and human retroviruses ,25(3): page 249-59[PubMed] [Google Scholar]

Zhu T, Corey L, Akridge R, Change Y, Feng F, Kim J, Alef C, Mcelroy J, Mullins J, Mcelrath J. Evidence for HIV-1 latent infection in exposed seronegative individuals.6thConference on Retroviruses and Opportunistic Infections. Chicago; 1999. Abstract No.8. [PubMed] [Google Scholar]

Zhu-Tuofu, Corey-Lawrence, Hwangbo-Yon, Lee-Jean-M, Learn-Gerald-H, Mullins-James-I, McElrath-M-Juliana. Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals. Journal of virology. 2003;(77)11:6108-16. [PubMed] [Google Scholar]

National Population Commission (NPC) [Nigeria] and ICF Macro; 2009. Nigeria Demographic and Health Survey. Abuja, Nigeria:National Population Commission and ICF Macro; 2008.

Cochran WG. Sampling techniques (3rded.), 605 third Avenue, New York, New York; 1977. 10016 by John Wiley& Sons inc, ISBN0-471-02939-4.

Ary D, Jacobs LC, Razavieh A. Introduction to research in education. Fort Worth,TX: Harcourt Brace College Publishers; 1996.

Bartlett JE, II Kotrlik JW, Higgins C. Organizational research Determining appropriate sample size for survey research, Information Technology, Learning, and Performance Journal. 2001;19(1):43-50. [PubMed] [Google Scholar]

Rao JNK. Sample size calaculation, by Raosoft, Inc; 2004. [PubMed] [Google Scholar]

Mabayoje VO, Akinwusi PO, Fadiora SO, Adeyeba OA, Aderounmu AO, Ebgewale EB. Sexual risk behaviour among young people in Osogbo, Osun state Nigeria. Trop Doct. 2005;35(4):213–215.

Thakral B, Saluja K, Sharma RR, Marwaha N. Algorithm for recall of HIV reactive Indian blood donors by sequential immunoassays enables selective donor referral for counseling. J Postgrad Med. 2006;52(2):106–10.

Marco Bani, Barbara Giussani. Gender differences in giving blood: a review of the literature Blood Transfus. 2010;8(4):278–287. DOI: 10.2450/2010.0156-09 PMCID: PMC2957494 PMID: 20967170 [PMC free article] [PubMed] [Google Scholar]

Samreen Siraj Bala, Shazia Handoo, Aleena Shafi Jallu. Gender Differences in Blood Donation among Donors of Kashmir Valley, OSR Journal of Dental and Medical Sciences (IOSR-JDMS)e-ISSN: 2279-0853, p-ISSN: 2279-0861. 2015;14(2)I:116-119. Available:www.iosrjournals.org DOI: 10.9790/0853-14214116119www.iosrjournals.org [PMC free article] [PubMed] [Google Scholar]

Tadele Girum, Abebaw Wasie, Kifle Lentiro, Ebrahim Muktar, Teha Shumbej, Mesfin Difer, Mulugeta Shegaze, Abdulsemed Worku. Gender disparity in epidemiological trend of HIV/AIDS infection and treatment in Ethiopia, Arch Public Health. 2018;76:51. DOI: 10.1186/s13690-018-0299-8 PMCID: PMC6139900PMID: 30237881[PMC free article] [PubMed] [CrossRef] [Google Scholar]

Monica Akinyi Magadi. Understanding the gender disparity in HIV infection across countries in sub-Saharan Africa: evidence from the Demographic and Health Surveys Sociol Health Illn. 2011;33(4):522– 539. DOI: 10.1111/j.1467-9566.2010.01304.x,PMCID: PMC3412216 ,PMID: 21545443[Google Scholar] PMC free article] [PubMed] [CrossRef]

Drissa Sia, Yentéma Onadja, Mohammad Hajizadeh, S. Jody Heymann, Timothy F. Brewer & Arijit Nandi. What explains gender inequalities in HIV/AIDS prevalence in sub-Saharan Africa? Evidence from the demographic and health surveys,BMC Public Health. 2016;16, Article number: 1136 (2016) [Google Scholar] PMC free article] [PubMed] [CrossRef]

Centers for Disease Control and Prevention. HIV Surveillance Report, 2017;29. Available:http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published November 2018. Accessed [date[PMC free article] [PubMed] [CrossRef] [Google Scholar]

Obire O, Nwankwo U. Jeniffer, Ramesh R. Putheti. Incidence of HIV and AIDS in Ahoada, Port Harcourt, Nigeria Electronic Journal of Biology. 2009;5(2):28-33. [PubMed] [Google Scholar]

Bassey, Antigha, Bassey, Umo Antigha, Okon Ottong, J. G. Ojua, Takin Asu, Conflicts between line and staff employee and the achievement of organisational goal and objectives: a study of University of Calabar Teaching Hospital Calabar,International Journal of Business and Social Science. 2012;3(6). [Special Issue -March 2012] [PubMed] [Google Scholar]

Saboor M, Ullah A, Qamar K, Mir A. Moinuddin. Frequency of ABH secretors and non- secretors: A cross sectional study in Karachi. Pak J Med Sci. 2014;30(1):189–93. DOI: http://dx.doi.org/10.12669/pjms.301.4194. [PMC free article] [PubMed] [Google Scholar] [Ref list].

Falusi AG, Ademowo OG, Latunji CA, Okeke AC, Olatunji PO, Onyekwere TO, Jimmy EO, Raji Y, Hedo CC, Otukonyong EE, Itata EO. Distribution of ABO and RH genes in Nigeria Afr J Med Med Sci. 2000;29(1):23-6. [PMC free article] [PubMed] [Google Scholar]

Dacie JV, Lewis SM. Practical Haematology 7th edition Churchill Livingstone, Edingburg, Londom, Melbourne and New York; 191. Chapter 1, 2 &5 Emeribe AO, Igweagu CA, Osim EE. ABH secretor status in residents of Calabar Municipality, East African Medical Journal. 1992;69(1):27-30. [PMC free article] [PubMed] [Google Scholar ]

Emeribe AO, Igweagu CA, Osim EE. ABH secretor status in residents of Calabar Municipality, East African Medical Journal. 1992;69(1):27-30. [PMC free article] [PubMed] [Google Scholar ]

Poonam Woike,Sudha Iyengar, Dharmesh Chandra Sharma, Rajesh Gaur. Frequency of ABH secretors /non-secretors and its Clinical Significance: A Cross Sectional Study in Gwalior IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861. 2017;16(6)II:116-124. Available:www.iosrjournals.org DOI: 10.9790/0853-160602116124

Available:www.iosrjournals.org [PMC free article] [PubMed] [Google Scholar]

Igbeneghu C, Odaibo GN, Olisekodiaka JM, Folarin O.R & Oseni BSA, ABO Blood Group and secretor status in HIV infection In Osogbo, Southwestern Nigeria, European Journal of Biotechnology and Genetic Engineering. 2014;1(1). [PMC free article] [PubMed] [Google Scholar]

Erhabor Osaro et al. Prevalence of p24 antigen among a cohort of HIV antibody negative blood donors in Sokoto, North Western Nigeria - the question of safety of blood transfusion in Nigeria. Pan African Medical Journal. 2014;18:174. DOI: 10.11604/pamj.2014.18.174.3449 [PMC free article] [PubMed] [Google Scholar]

Muhammad Saboor, Aman Ullah, Khansa Qamar, Awal Mir MoinuddinFrequency of ABH secretors and non secretors: A cross sectional study in Karachi Pak J Med Sci2014;30(1):189-93. DOI: 10.12669/pjms.301.4194. DOI: 10.12669/pjms.301.4194 [PMC free article] [PubMed] [Google Scholar]

Rashmi Metgud, Nidi Khajauria, Gayathri Ramesh. Journal Clinical Diagnostic Research: 2016:10(2) ZC01-ZC03. [PMC free article] [PubMed] [Google Scholar]

Barletta JM, Edelman DC, Constantine NT. Lowering the detection limits of HIV-1 viral load using real-time immuno-PCR for HIV-1 p24 antigen. Am J Clin Pathol. 2004;122(1):20-27. DOI:10.1309/529T-2WDN-EB6X-8VUN